Export file:

Format

  • RIS(for EndNote,Reference Manager,ProCite)
  • BibTex
  • Text

Content

  • Citation Only
  • Citation and Abstract

Blood Pressure Monitoring in Cardiovascular Disease

1 Mariñamansa-A Cuña Health Center, Galician Health Service, Ourense, Spain
2 University of Valencia Clinical Teaching Hospital, Valencia, Spain
3 Nutricia. Madrid, Spain

While the practice of taking blood pressure readings at the physician’s office continues to be valid, home blood pressure monitoring is being increasingly used to enhance diagnostic accuracy and ensure a more personalized follow-up of patients. In the case of white coat hypertension and resistant arterial hypertension, ambulatory blood pressure monitoring is indispensable. Recent studies attach great importance to nocturnal blood pressure patterns, with a reduction in these becoming a treatment goal, a strategy known as chronotherapy. Home blood pressure monitoring is useful for both diagnosis and follow-up of arterial hypertension. Its use, particularly if combined with other patient-support interventions, serves to improve blood pressure control. Telemonitoring is associated with a decrease in blood pressure values and an increase in patient satisfaction. All studies highlight the importance of patients being supported by a multidisciplinary health care team, since blood pressure telemonitoring with a support team is more effective than simple data telemonitoring. Further studies are called for, especially on the illiterate population, with difficulties posed by technological accessibility and transcriptions into different languages. More cost-effectiveness studies and long-term results are needed to ascertain the true benefit of blood pressure telemonitoring.
  Figure/Table
  Supplementary
  Article Metrics

Keywords ambulatory blood pressure; cardiovascular medicine; cardiovascular diseases; hypertension; telemedicine; combined modality therapy; telecommunications networks

Citation: Carlos Menéndez Villalva, Xose Luis Muiño López-Alvarez, Martín Menéndez Rodríguez, María José Modroño Freire, Olalla Quintairos Veloso, Lea Conde Guede, Sandra Vilchez Dosantos, Manuel Blanco Ramos. Blood Pressure Monitoring in Cardiovascular Disease. AIMS Medical Science, 2017, 4(2): 164-191. doi: 10.3934/medsci.2017.2.164

References

  • 1. Bonafini S, Fava C (2015) Home blood pressure measurements: Advantages and disadvantages compared to office and ambulatory monitoring. Blood Press 24: 325–332.    
  • 2. Wolak T, Wilk L, Paran E, et al. (2013) Is it possible to shorten ambulatory blood pressure monitoring? J Clin Hypertens (Greenwich) 15: 570–574.    
  • 3. O'Brien E, Parati G, Stergiou G, et al. (2013) European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens 31: 1731–1768.    
  • 4. Norma M Kaplan, George Tomas, Marc Pohl, et al. (2016) Blood pressure measurement in the diagnosis and management of hypertension in adults.
  • 5. Krause T, Lovibond K, Caulfield M, et al. (2011) Management of hypertension: summary of NICE guidance. BMJ (Clinical Res) 343: 1–6.
  • 6. Siu AL, U.S. Preventive Services Task Force (2015) Screening for high blood pressure in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 163: 778–786.
  • 7. Chobanian AV, Bakris GL, Black HR, et al. (2003) Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42: 1206–1252.    
  • 8. Kaplan NM, Townsend RR (2015) Ambulatory and home blood pressure monitoring and white coat hypertension in adults.
  • 9. Hermida RC, Ayala DE, Portaluppi F (2007) Circadian variation of blood pressure: The basis for the chronotherapy of hypertension. Advance Drug Delivery Rev 9: 904–922.
  • 10. Andersen MJ, Khawandi W, Agarwal R (2005) Home blood pressure monitoring in CKD. Am J Kidney Dis 45: 994–1001.    
  • 11. Pickering TG, Miller NH, Ogedegbe G, et al. (2008) Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension 52: 10–29.    
  • 12. Parati G, Pickering TG (2009) Home blood-pressure monitoring: US and European consensus. Lancet 373: 876–878.    
  • 13. Niiranen TJ, Hänninen MR, Johansson J, et al. (2010) Home-measured blood pressure is a stronger predictor of cardiovascular risk than office blood pressure: The finn-home study. Hypertension 55: 1346–1351.    
  • 14. Verberk WJ, Kroon AA, Kessels AGH, et al. (2005) Home blood pressure measurement: A systematic review. J Am College Cardiology 46: 743–751.    
  • 15. Myers MG (2010) A proposed algorithm for diagnosing hypertension using automated office blood pressure measurement. J Hypertension 28: 703–708.    
  • 16. Powers BJ, Olsen MK, Smith VA, et al. (2011) Measuring blood pressure for decision making and quality reporting: Where and how many measures? Ann Intern Med 154: 781–788.    
  • 17. Mesas A E, Leon-muñoz L, Rodriguez-artalejo F, et al. (2011) The effect of coffee on blood pressure and cardiovascular disease among hypertensive individuals: Meta-analysis. J Clinical Hypertension 13: A42.    
  • 18. Other U (2001) Blood pressure measurement. BMJ 322: 1043–1047.    
  • 19. Pickering TG, Hall JE, Appel LJ, et al.(2005) Recommendations for blood pressure measurement in humans: an AHA scientific statement from the Council on high blood pressure research professional and public education subcommittee.J Cinical Hypertens 7: 102–109.
  • 20. Mancia G, Fagard R, Narkiewicz K, et al. (2013) ESH/ESC Guidelines for the management of arterial hypertension. J Hypertens 31: 1281–1357.    
  • 21. Mancia G, De Backer G, Dominiczak A, et al. (2007) ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 25: 1751–1762.    
  • 22. O'Brien (2005) Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens 23: 697–701.    
  • 23. U.S. Preventive Services Task Force (2007) Screening for high blood pressure: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med 147(11):783–786.
  • 24. Franklin SS, Thijs L, Hansen TW, et al. (2013) White-coat hypertension new insights from recent studies. Hypertension 62: 982–987.    
  • 25. NICE (2011) Hypertension in adults: diagnosis and management. NICE Guidel :1–38.
  • 26. James PA, Oparil S, Carter BL, et al. (2013) Evidence-Based Guideline for the Management of High Blood Pressure in Adults. Jama 1097: 1–14.
  • 27. Coca A, Bertomeu V, Dalfó A, et al. (2007)Blood pressure self measurement: Spanish consensus document. Nefrol Publicación La Soc Española Nefrol 27: 139–153
  • 28. Bangalore S, Qin J, Sloan S, et al. (2010) What is the optimal blood pressure in patients after acute coronary syndromes? Circulation 122: 2142–2151.    
  • 29. Vokó Z, Bots ML, Hofman A, et al. (1999) shaped relation between blood pressure and stroke in treated hypertensives. Hypertension 34: 1181–1185.    
  • 30. Pahor M, Shorr RI, Cushman WC, et al. (1999) The role of diastolic blood pressure when treating isolated systolic hypertension. Arch Intern Med 159: 2004–2009.    
  • 31. Pickering TG (1988) The influence of daily activity on ambulatory blood pressure. Am Hear Jan 116: 1141–1146.    
  • 32. Agarwal R, Andersen M (2006) Prognostic importance of ambulatory blood pressure recordings in patients with chronic kidney disease. Kidney Int 69: 1175–1180.    
  • 33. Asayama K, Ohkubo T, Kikuya M, et al (2004) Prediction of stroke by self-measurement of blood pressure at home versus casual screening blood pressure measurement in relation to the Joint National Committee 7 classification: The Ohasama study. Stroke 35: 2356–2361.    
  • 34. Agarwal R, Bills JE, Hecht TJW, et al. (2011) Role of home blood pressure monitoring in overcoming therapeutic inertia and improving hypertension control. Hypertension 57: 29–38.    
  • 35. Uhlig K, Patel K, Ip S, et al. (2013) Self-Measured Blood Pressure Monitoring in the Management of Hypertension. A systematic review and meta-analysis. Improve Patient Care 159.
  • 36. Cappuccio FP, Kerry SM, Forbes L, et al. (2004) Blood pressure control by home monitoring: meta-analysis of randomised trials. Br Med J 329: 145.    
  • 37. Powers BJ, Adams MB, Svetkey LP, et al. (2009) Two Self-management Interventions to Improve Hypertension Control. Ann Intern Med 151: 687–696.    
  • 38. McManus RJ, Mant J, Haque MS, et al.(2014) Effect of Self-monitoring and Medication Self-titration on Systolic Blood Pressure in Hypertensive Patients at High Risk of Cardiovascular Disease. Jama 312: 799.
  • 39. McManus RJ, Mant J, Bray EP, et al (2010) Telemonitoring and self-management in the control of hypertension (TASMINH2): A randomised controlled trial. Lancet 376: 163–172.    
  • 40. Yi SS, Tabaei BP, Angell SY, et al. (2015) Self-blood pressure monitoring in an urban, ethnically diverse population: a randomized clinical trial utilizing the electronic health record. Circulation 138–145.
  • 41. Parati G, Stergiou GS, Asmar R, et al. (2010) European Society of Hypertension practice guidelines for home blood pressure monitoring. J Hum Hypertens 24: 779–785.    
  • 42. Dasgupta K, Quinn RR, Zarnke KB, et al.(2014) The 2014 Canadian hypertension education program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol 30: 485–501.
  • 43. Daskalopoulou SS, Rabi DM, Zarnke KB, et al. (2015) The 2015 Canadian Hypertension Education Program Recommendations for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension. Can J Cardiol 31: 549–568.    
  • 44. Avenue G (2011) Optimal Schedule for Home Blood Pressure Measurement. Hypertension 1081–1086.
  • 45. Lauer RM, Clarke WR (1989) Childhood risk factors for high adult blood pressure: the Muscatine Study. Pediatrics 84: 633–641.
  • 46. Sun SS, Grave GD, Siervogel RM, et al. (2007) Systolic blood pressure in childhood predicts hypertension and metabolic syndrome later in life. Pediatrics 119: 237–246.    
  • 47. Blumenthal S, Epps R, Heavenrich R (1987) Report of the Second Task Force on Blood Pressure Control in Children. Pediatrics 79: 797–820.
  • 48. The Fourth Report on the Diagnosis, Evaluation and T of HBP in C and A (2004) National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. Pediatrics 114: 555–576.    
  • 49. Rosner B, Prineas RJ, Loggie JMH, et al. (1993) Blood pressure nomograms for children and adolescents, by height, sex, and age, in the United States. J Pediatr 123(6): 871–886.
  • 50. Joseph T Flynn (2017) Ambulatory blood pressure monitoring in children.
  • 51. Williams CL, Daniels SR, Robinson TN, et al. (2002) Cardiovascular health in childhood. A statement for health professionals from the committee on atherosclerosis, hypertension, and obesity in the young of the council on cardiovascular disease in the young, Americam Heart Association. Circulation 106: 143–160.
  • 52. Flynn JT (2011) Ambulatory blood pressure monitoring in children: imperfect yet essential. Pediatr Nephrol 26: 2089–2094.    
  • 53. Sorof JM, Poffenbarger T, Franco K, et al. (2001) Evaluation of white coat hypertension in children: Importance of the definitions of normal ambulatory blood pressure and the severity of casual hypertension. Am J Hypertens 14: 855–860.    
  • 54. Lande MB, Meagher CC, Fisher SG, et al. (2008) Left ventricular mass index in children with white coat hypertension. J Pediatr153: 50–54.
  • 55. Seeman T, Palyzová D, Dušek J, et al. (2017) Reduced nocturnal blood pressure dip and sustained nighttime hypertension are specific markers of secondary hypertension. J Pediatr 147: 366–371.
  • 56. Flynn J, Daniels S, Hayman L, et al.(2014) Update: Ambulatory blood pressure monitoring in children and adolescents: A scientific statement from the American Heart Association. Hypertension 63: 1116–1135.
  • 57. Urbina E, Alpert B, Flynn J, et al. (2008) Ambulatory Blood Pressure Monitoring in Children and Adolescents: Recommendations for Standard Assessment: A Scientific Statement From the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the Council on Cardiovas. Hypertension 52: 433–451.    
  • 58. Aronow WS, Fleg JL, Pepine CJ, et al. (2011) Expert Consensus Document ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly. J Am College Cardiology 57: 2037–2114.    
  • 59. Ishikawa J, Ishikawa Y, Edmondson D, et al. (2011) Age and the difference between awake ambulatory blood pressure and office blood pressure: a meta-analysis. Blood Press Monit 16: 159–167.    
  • 60. Stergiou GS, Ntineri A, Kollias A (2017) Changing relationship among office, ambulatory, and home blood pressure with increasing age: A neglected issue. Hypertension 64: 931–932.
  • 61. US Preventive Services Task Force (2017) Final Recommendation Statement: High Blood Pressure in Adults.
  • 62. Weber MA, Schiffrin EL, White WB, et al. (2014) Clinical Practice Guidelines for the Management of Hypertension in the Community. J Clin Hypertens 16: 14–26.    
  • 63. Bangalore S, Messerli FH, Wun CC, et al. (2010) J-curve revisited: An analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial. Eur Heart J 31: 2897–2908.    
  • 64. Maselli M, Giantin V, Franchin A, et al. (2014) Detection of blood pressure increments in active elderly individuals: the role of ambulatory blood pressure monitoring. Nutr Metab Cardiovasc Dis 24: 914–920.    
  • 65. Angeli F, Reboldi G, Verdecchia P (2010) Masked hypertension: Evaluation, prognosis, and treatment. Am J Hypertens 23: 941–948.    
  • 66. Cacciolati C, Hanon O, Alpérovitch A, et al. (2011) Masked hypertension in the elderly: cross-sectional analysis of a population-based sample. Am J Hypertens 24: 674–680.    
  • 67. Verberk WWJ, Omboni S, Kollias A, et al. (2016) Screening for atrial fibrillation with automated blood pressure measurement: Research evidence and practice recommendations. Int J Cardiol 203: 465–473.    
  • 68. Calhoun D A, Jones D, Textor S, et al. (2008) Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 117: 1403–1419.
  • 69. De la Sierra A, Segura J, Banegas JR, et al.(2011) Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension 57: 898–902.
  • 70. Jiménez Navarro MF (2016) Comentarios a la guía ESC 2016 sobre prevención de la enfermedad cardiovascular en la práctica clínica. Rev Española Cardiol 69: 894–899.    
  • 71. Pickering TG (1988) Blood pressure monitoring outside the office for the evaluation of patients with resistant hypertension. Hypertension 11: II96-100.
  • 72. Lazaridis AA, Sarafidis PA, Ruilope LM (2015) Ambulatory Blood Pressure Monitoring in the Diagnosis, Prognosis, and Management of Resistant Hypertension: Still a Matter of our Resistance? Curr Hypertens Rep 17.
  • 73. Brown MA, Buddle ML, Martin A (2001) Is resistant hypertension really resistant? Am J Hypertens 14: 1263–1269.    
  • 74. Ríos M, Domínguez-Sardiña M, Ayala D, et al. (2013) Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring. Chronobiol Int 30.
  • 75. Cardoso CRL, Salles GF (2016) Prognostic Importance of Ambulatory Blood Pressure Monitoring in Resistant Hypertension: Is It All that Matters? Curr Hypertens Rep 18: 85.    
  • 76. Salles GF, Cardoso CL, Muxfeldt ES (2008) Prognostic influence of office and ambulatory blood pressures in resistant hypertension. Arch Intern Med 168: 2340–2346.    
  • 77. Ayala DE, Hermida RC, Mojón A, et al. (2012) Cardiovascular Risk of Resistant Hypertension: Dependence on Treatment-Time Regimen of Blood Pressure–Lowering Medications. Chronobiol Int 528: 1–13.
  • 78. Calhoun DA, Raymond MD, Townsens MD (2016) Treatment of resistant hypertension.
  • 79. Doroszko A, Janus A, Szahidewicz-Krupska E, et al. (2016) Resistant hypertension. Adv Clin Exp Med 25: 173–183.    
  • 80. Muxfeldt E, Bloch K, Nogueira A, et al. (2003) Twenty-four hour ambulatory blood pressure monitoring pattern of resistant hypertension. Blood Press Monit 8: 181–185.
  • 81. Muxfeldt ES, Salles GF (2013) How to use ambulatory blood pressure monitoring in resistant hypertension. Hypertens Res 36: 385–389.    
  • 82. Williams B, Macdonald TM, Morant S, et al. (2015) Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (Pathway-2): A randomised, double-blind, crossover trial. Lancet 386: 2059–2068.    
  • 83. Dudenbostel T, Siddiqui M, Oparil S, et al. (2016) Refractory hypertension: A novel phenotype of antihypertensive treatment failure. Hypertension 67: 1085–1092.    
  • 84. Hermida RC, Smolensky MH, Ayala DE, et al. (2013) Recomendaciones 2013 para el uso de la monitorización ambulatoria de la presión arterial para el diagnóstico de hipertensión en adultos, valoración de riesgo cardiovascular y obtención de objetivos terapéuticos (resumen). Clínica e Investig en Arterioscler 25: 74–82.    
  • 85. Sheikh S, Sinha A, Agarwal R (2011) Home Blood Pressure Monitoring: How Good a Predictor of Long-Term Risk? Curr Hypertens Rep 13: 192–199.    
  • 86. Hermida RC, Moyá A, Ayala DE (2015) Monitorización ambulatoria de la presión arterial en diabetes para valoraci??n y control de riesgo vascular. Endocrinologiay Nutricion 62: 400–410.
  • 87. Mancia G, Verdecchia P (2015) Clinical Value of Ambulatory Blood Pressure: Evidence and Limits. Circ Res 116: 1034–1045.    
  • 88. Leitão CB, Canani LH, Silveiro SP, et al. (2007) Ambulatory blood pressure monitoring and type 2 diabetes mellitus. Arq Bras Cardiol 89: 315–321, 347–354
  • 89. Care D (2016) Standards of Medical Care in Diabetes : Summary of Revisions. Diabetes Care 39: S4–5.    
  • 90. Coca A, Camafort M, Doménech M, et al. (2013) Ambulatory blood pressure in stroke and cognitive dysfunction. Curr Hypertens Rep 15: 150–159.    
  • 91. Castilla-Guerra L, Fernández-Moreno M del C, Espino-Montoro A, et al. (2009) Ambulatory blood pressure monitoring in stroke survivors: Do we really control our patients? Eur J Intern Med 20: 760–763.    
  • 92. Castilla-Guerra L, Fernandez-Moreno (2016) Chronic Management of Hypertension after Stroke: The Role of Ambulatory Blood Pressure Monitoring. J stroke 18: 31–37.    
  • 93. Agarwal R (2009) Home and ambulatory blood pressure monitoring in chronic kidney disease. Curr Opin Nephrol Hypertens 18: 507–512.    
  • 94. Agarwal R, Peixoto AJ, Santos SFF, et al. (2009) Out-of-office blood pressure monitoring in chronic kidney disease. Blood Press Monit 14: 2–11.    
  • 95. Parati G, Ochoa JE, Bilo G, et al.(2016) Hypertension in chronic kidney disease part 1: Out-of-office blood pressure monitoring: Methods, thresholds, and patterns. Hypertension 67: 1093–1101.
  • 96. Mehta R, Drawz PE (2011) Is nocturnal blood pressure reduction the secret to reducing the rate of progression of hypertensive chronic kidney disease? Curr Hypertens Rep 13: 378–385.    
  • 97. Verdecchia P (2000) Prognostic value of ambulatory blood pressure : current evidence and clinical implications. Hypertension 35: 844–851.    
  • 98. O'Brien E, Sheridan J, O'Malley K (1988) Dippers and Non-dippers. Lancet 332: 397.
  • 99. Kario K, Pickering TG, Umeda Y, et al. (2003) Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: A prospective study. Circulation 107: 1401–1406.    
  • 100. Muller JE, Abela GS, Nesto RW, et al. (1994)Triggers, acute risk factors and vulnerable plaques: The lexicon of a new frontier. J Am College Cardiology 23: 809–813.
  • 101. Li Y, Thijs L, Hansen TW, et al. (2010) Prognostic value of the morning blood pressure surge in 5645 subjects from 8 populations. Hypertension 55: 1040–1048.    
  • 102. Neutel JM, Schnaper H, Cheung DG, et al. (1990) Antihypertensive effects of β-blockers administered once daily: 24-hour measurements. Am Heart J 120: 166–171.    
  • 103. Meredith PA, Donnelly R, Elliott HL, et al. (1990) Prediction of the antihypertensive response to enalapril. J Hypertens 8: 1085–1090.    
  • 104. Hermida RC, Calvo C, Ayala DE, et al. (2005) Treatment of non-dipper hypertension with bedtime administration of valsartan. J Hypertens 23: 1913–1922.    
  • 105. Kikuya M, Ohkubo T, Asayama K, et al. (2005) Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality: The Ohasama study. Hypertension 45: 240–245.    
  • 106. Ben-Dov IZ, Kark JD, Ben-Ishay D, et al. (2007) Predictors of All-Cause Mortality in Clinical Ambulatory Monitoring. Hypertension 49: 1235–1241.    
  • 107. Boggia J, Li Y, Thijs L, et al.(2007) Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet 370: 1219–1229.
  • 108. Fagard RH, Celis H, Thijs L, et al. (2008) Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension 51: 55–61.    
  • 109. Fan H-Q, Li Y, Thijs L, et al. (2010) Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J Hypertens 28: 2036–2045.    
  • 110. Hermida RC, Ayala DE, Mojón A, et al. (2011) Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk. J Am Coll Cardiol 58: 1165–1173.    
  • 111. Hermida RC, Ayala DE, Mojón A, et al. (2010) Influence of circadian time of hypertension treatment on cardiovascular risk:results of the MAPEC study. Chronob 278: 1629–1651.
  • 112. Hermida RC, Ayala DE, Mojón A, et al. (2011) Influence of time of day of blood pressure-lowering treatment on cardiovascular risk in hypertensive patients with type 2 diabetes. Diabetes Care 34: 1270–1276.    
  • 113. Hermida RC, Ayala DE, Mojon A, et al. (2011) Bedtime Dosing of Antihypertensive Medications Reduces Cardiovascular Risk in CKD. J Am Soc Nephrol 22: 2313–2321.    
  • 114. Pogue V, Rahman M, Lipkowitz M, et al. (2008) Disparate Estimates of Hypertension Control From Ambulatory and Clinic Blood Pressure Measurements in Hypertensive Kidney Disease. Hypertension 53.
  • 115. Hermida RC (2007)Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study. Chronobiol Int 24: 749–775.
  • 116. Minutolo R, Gabbai FB, Borrelli S, et al.(2007) Changing the Timing of Antihypertensive Therapy to Reduce Nocturnal Blood Pressure in CKD: An 8-Week Uncontrolled Trial. Am J Kidney Dis 50: 908–917.
  • 117. Hermida RC, Ayala DE, Fernández JR, et al. (2008) Chronotherapy improves blood pressure control and reverts the nondipper pattern in patients with resistant hypertension. Hypertension 51: 69–76.    
  • 118. Carter BL, Chrischilles EA, Rosenthal G, et al. (2014) Efficacy and Safety of Nighttime Dosing of Antihypertensives: Review of the Literature and Design of a Pragmatic Clinical Trial. J Clin Hypertens 16: 115–121.    
  • 119. Ohkubo T, Imai Y, Tsuji I, et al. (1997) Prediction of mortality by ambulatory blood pressure monitoring versus screening blood pressure measurements: a pilot study in Ohasama. J Hypertens 15: 357–364.    
  • 120. Guidelines JCS (2012) Guidelines for the Clinical Use of 24 Hour Ambulatory Blood Pressure Monitoring (ABPM) (JCS 2010). Circ J 76: 508–519.    
  • 121. Verdecchia P, Angeli F, Mazzotta G, et al. (2012) Day-night dip and early-morning surge in blood pressure in hypertension: Prognostic implications. Hypertension :34–42.
  • 122. Glynn LG, Murphy AW, Smith SM, et al. (2010) Interventions used to improve control of blood pressure in patients with hypertension. The Cochrane.
  • 123. Santschi V, Chiolero A, Colosimo AL, et al. (2014) Improving Blood Pressure Control Through Pharmacist Interventions: A Meta-Analysis of Randomized Controlled Trials. J Am Heart Assoc 3: e000718.    
  • 124. Floras JS (2007) Ambulatory blood pressure: facilitating individualized assessment of cardiovascular risk. J Hypertens 25: 1565–1568.    
  • 125. Home. Available from: https://medicalhomeinfo.aap.org/Pages/default.aspx
  • 126. Ahern DK, Stinson LJ, Uebelacker LA, et al. (2012) E-health blood pressure control program. J Med Pract Manag 28: 91–100.
  • 127. Anthony CA, Polgreen LA, Chounramany J, et al. (2015) Outpatient blood pressure monitoring using bi-directional text messaging. J Am Soc Hypertens 9: 375–381.    
  • 128. Zullig LL, Dee Melnyk S, Goldstein K, et al. (2013) The role of home blood pressure telemonitoring in managing hypertensive populations. Curr Hypertens Rep 15: 346–355.    
  • 129. Margolis KLK, Asche SES, Bergdall AAR, et al. (2013) Effect of Home Blood Pressure Telemonitoring and Pharmacist Management on Blood Pressure Control. Jama 310: 46.    
  • 130. Margolis KLK, Asche SES, Bergdall ARA, et al (2015) A Successful Multifaceted Trial to Improve Hypertension Control in Primary Care: Why Did it Work? J Gen Intern Med 30: 1665–1672.    
  • 131. Green B, Cook A, Ralston J, et al. (2008) Effectiveness of Home Blood Pressure Monitoring, Web Communication, and Pharmacist Care on Hypertension Control: The e-BP Randomized Controlled Trial. Jama 299: 2857–2867.    
  • 132. Fishman PA, Cook AJ, Anderson ML, et al. (2013) Improving BP control through electronic communications: An economic evaluation. Am J Manag Care 19: 709–716.
  • 133. Polgreen LA, Han J, Carter BL, et al. (2015) Cost-Effectiveness of a Physician-Pharmacist Collaboration Intervention to Improve Blood Pressure Control. Hypertension 66: 1145–1151.
  • 134. Robins LS, Jackson JE, Green BB, et al. (2013) Barriers and facilitators to evidence-based blood pressure control in community practice. J Am Board Fam Med 26: 539–557.    
  • 135. Magid D J, Olson K L, Billups S J, et al. (2013) A pharmacist-led, American heart association Heart360 web-enabled home blood pressure monitoring program. Circulation 6: 157–163.
  • 136. Bosworth H B, Powers B J, Olsen M K, et al. (2011) Home blood pressure management and improved blood pressure control: Results from a randomized controlled trial. Arch Int Med 171: 1173–1180.    
  • 137. Omboni S, Sala E (2015) The pharmacist and the management of arterial hypertension: the role of blood pressure monitoring and telemonitoring. Expert Rev Cardiovasc Ther13: 209–221.
  • 138. Ernst ME (2013) Ambulatory blood pressure monitoring: recent evidence and clinical pharmacy applications. Pharmacotherapy 33: 69–83.    
  • 139. James K, Dolan E, O'Brien E (2014). Making ambulatory blood pressure monitoring accessible in pharmacies. Blood Press Monit 19: 134–139.    
  • 140. Gregoski MJ, Vertegel A, Shaporev A, et al. (2013) Tension Tamer: delivering meditation with objective heart rate acquisition for adherence monitoring using a smart phone platform. J Altern Complement Med 19: 17–19.    
  • 141. Rifkin DE, Abdelmalek JA, Miracle CM, et al. (2013) Linking clinic and home: a randomized, controlled clinical effectiveness trial of real-time, wireless blood pressure monitoring for older patients with kidney disease and hypertension. Blood Press Monit 18: 8–15.    
  • 142. Kim KB, Han HR, Huh B, et al. (2014). The effect of a community-based self-help multimodal behavioral intervention in Korean American seniors with high blood pressure. Am J Hypertens 27: 1199–1208.    
  • 143. Sieverdes JC, Treiber F, Jenkins C, et al. (2013). Improving Diabetes Management With Mobile Health Technology. Am J Med Sci 345: 289–295.    
  • 144. O'Reilly DJ, Bowen JM, Sebaldt RJ, et al. (2014) Evaluation of a Chronic Disease Management System for the Treatment and Management of Diabetes in Primary Health Care Practices in Ontario: An Observational Study. Ont Heal Technol Assess Ser14: 1–37.
  • 145. Green BB, Anderson ML, Cook AJ, et al. (2014) E-care for heart wellness: A feasibility trial to decrease blood pressure and cardiovascular risk. Am J Prev Med 46: 368–377.    
  • 146. Gandhi PU, Pinney S (2014) Management of chronic heart failure: biomarkers, monitors, and disease management programs. Ann Glob Heal 80: 46–54.    
  • 147. Aberger EW, Migliozzi D, Follick MJ, et al. (2014). Enhancing Patient Engagement and Blood Pressure Management for Renal Transplant Recipients via Home Electronic Monitoring and Web-Enabled Collaborative Care. Telemed J e-Health 20: 850–854.    
  • 148. Neumann CL, Schulz EG (2014) Interventionelles dezentrales Telemonitoring: Mögliche Indikationen und Perspektiven einer neuen Methode in der Telemedizin. Praxis 103: 519–526.    

 

This article has been cited by

  • 1. Han Ouyang, Jingjing Tian, Guanglong Sun, Yang Zou, Zhuo Liu, Hu Li, Luming Zhao, Bojing Shi, Yubo Fan, Yifan Fan, Zhong Lin Wang, Zhou Li, Self-Powered Pulse Sensor for Antidiastole of Cardiovascular Disease, Advanced Materials, 2017, 1703456, 10.1002/adma.201703456

Reader Comments

your name: *   your email: *  

Copyright Info: © 2017, Carlos Menéndez Villalva, et al., licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution Licese (http://creativecommons.org/licenses/by/4.0)

Download full text in PDF

Export Citation

Copyright © AIMS Press All Rights Reserved